Effect of Blood Flow Restriction on Football-Related Performance Parameters

January 20, 2024 updated by: Begum Kara Kaya, Biruni University

Improvement of Football-Related Performance Parameters: Application of Blood Flow Restrictive Exercise

The blood flow restriction method can have similar or superior effects to high-intensity exercises even in a short duration, which can positively affect some performance parameters, can be applied with low-intensity load and cause hypertrophy in the muscle by providing high metabolic stress, facilitating muscle growth without significantly changing the total training dose. The aim of this study is to investigate whether adding the blood flow restriction method to the classical training program can be more effective than the classical training applied alone in the development of football-related performance parameters.

Study Overview

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Istanbul, Turkey
        • Biruni University
      • Istanbul, Turkey
        • İstanbul University Cerrahpaşa

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 30 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Being a male between the ages of 18-30 years
  • Volunteer to participate in the study
  • Playing football in one of the clubs in Istanbul for at least 1 year
  • Being in the pre-season of the club
  • Absence of any ongoing musculoskeletal problems that limit exercising

Exclusion Criteria:

  • Having at least one of the contraindications preventing the application of blood flow restriction (Smoking, previous venous thromboembolism, risk of peripheral vascular disease (ankle-brachial index <0.9), coronary heart disease, hypertension, hemophilia, etc.).
  • History of sports injury in the last 6 months
  • Orthopedic lower extremity surgery in the last 1 year
  • Body mass index ≥ 30 kg/m2

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Blood Flow Restriction + Classical Training
Blood flow restriction with low load (30-50% 1RM) for 2 sessions in a week for 6 weeks during classical training will be applied.
Experimental: Classical Training Alone
Classical training same as Group 1with moderate to high load (70-90% 1RM) for 2 sessions in a week for 6 weeks will be applied without blood restriction.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of Muscle Strength and Endurance
Time Frame: 6 weeks
Isokinetic dynamometer
6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of Lower Extremity Power
Time Frame: 6 weeks
Vertical jump test
6 weeks
Evaluation of Aerobic Endurance
Time Frame: 6 weeks
Yo-Yo Intermittent Recovery Level 1 test
6 weeks
Evaluation of Change of Direction Speed
Time Frame: 6 weeks
T Test
6 weeks
Evaluation of Reactive Agility
Time Frame: 6 weeks
Y-Shaped Reactive Agility Test
6 weeks
Evaluation of Dynamic Balance
Time Frame: 6 weeks
Y Balance Test
6 weeks
Systemic Fatigue
Time Frame: 6 weeks
Lactate analysis
6 weeks
General Perceived Fatigue
Time Frame: 6 weeks
Borg scale
6 weeks
Evaluation of General Satisfaction and Perceived Performance Change
Time Frame: 6th week
General satisfaction and the change in performance perceived by the participants will be evaluated with the 7 points Global Rating of Change Scale after the training program. According to the scale, it is expressed as "-3: I am much worse, -2: I am worse, -1: I am a little worse, 0: No change, 1: I am a little better, 2: I am better, 3: I am much better".
6th week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Ayse Zengin Alpözgen, PhD, Istanbul University - Cerrahpasa (IUC)

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 12, 2022

Primary Completion (Actual)

April 27, 2023

Study Completion (Actual)

October 27, 2023

Study Registration Dates

First Submitted

June 1, 2022

First Submitted That Met QC Criteria

July 6, 2022

First Posted (Actual)

July 11, 2022

Study Record Updates

Last Update Posted (Estimated)

January 23, 2024

Last Update Submitted That Met QC Criteria

January 20, 2024

Last Verified

June 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • DrTez

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Exercise

Clinical Trials on Blood Flow Restriction

Subscribe